Provisions of the IDE Regulation - 21 CFR 812
{"Image DocumentName": "Provisions of the IDE Regulation - 21 CFR 812", "Image ImageDescription": "Submission process of an IDE application to FDA for significant risk device studies. Process for obtaining IDE for non-significant risk device studies. Assigns responsibilities: sponsor and clinical investigator. Investigator agreement. Device accountability. Reporting and records. IRB review and informed consent.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}